跳至主要内容
临床试验/CTRI/2012/10/003075
CTRI/2012/10/003075尚未招募4 期

Open-label,Multicentre, Observational, Prospective, Real-time data capturing of Usage, Outcome & Physician satisfaction of Coseal in Cardio-Vascular-Thoracic Operative and Re-operative procedures - Coseal Registry

Medanta The Medicity0 个研究点目标入组 750 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
入组人数
750

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • 1.Patients undergoing cardiovascular and thoracic surgery who require use of Coseal as a treatment strategy.
  • 2.Patient undergoing open, Video Assisted surgery and robotic surgery to be included and analysed as subgroups
  • 3.Written informed consent obtained from the patient or legal representative for data collection post surgery in patients who had Coseal used intraoperatively (data privacy laws).

排除标准

  • 1.Known hypersensitivity to components of the investigational product
  • 2.Known Immune system disorders, immunodeficiency
  • 3.Concomitant use of any other anti-adhesion product
  • 4.Concurrently participating in another clinical trial and having received another investigational drug or device within the last 30 days
  • 5.Unplanned re-operation in case of use for anti-adhesion
  • 6.Contraindications for use of Coseal

研究者

相似试验

尚未招募
不适用
Study to compare the safety, tolerability and effectiveness of topical Minoxidil 5% solution in Indian male patients with mild to moderate pattern hair loss
CTRI/2021/09/036777Hairrevive Centre for Hair Restoration Skin Rejuvenation
进行中(未招募)
1 期
Prospective, randomized, multicenter, open label, phase II / III study to assess efficacy and safety of ranibizumab 0.5 mg intravitreal injections plus panretinal photocoagulation (PRP) versus PRP in monotherapy in the treatment of subjects with high risk proliferative diabetic retinopathy. (PROTEUS)
EUCTR2013-003640-23-GBAIBILI - Association for Innovation and Biomedical Research on Light and Image94
进行中(未招募)
1 期
Prospective, randomized, multicenter, open label, phase II / III study to assess efficacy and safety of ranibizumab 0.5 mg intravitreal injections plus panretinal photocoagulation (PRP) versus PRP in monotherapy in the treatment of subjects with high risk proliferative diabetic retinopathy. (PROTEUS)
EUCTR2013-003640-23-PTAIBILI - Association for Innovation and Biomedical Research on Light and Image94
已完成
不适用
PORTRAIT studyHypertgemiaD050171
JPRN-jRCTs041200011Sumida Yoshio80
招募中
不适用
Prospective, open-label, multicentre, non-randomized, non-interventional, exploratory, comparative, uncontrolled Post Market Clinical Follow-Up Study of the Modular Revision Support (MRS)-Titan® ComfortM16M87Coxarthrosis [arthrosis of hip]Osteonecrosis
DRKS00014369PETER BREHM GmbH120